PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development
PsyBio Therapeutics Further Expands Testing of Portfolio Compounds OXFORD, Ohio and COCONUT CREEK, Fla., May 6, 2022 /CNW/ - ...
